This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.

"Developments in Pharmaceutical and Biotech Patent Law" PLI, New York City, September 11, 20…

September 11, 2008 and October 15, 2008

"Developments in Pharmaceutical and Biotech Patent Law" PLI, New York City, September 11, 2008 and San Francisco, October 15, 2008

David Barr and Daniel Reisner co-chaired, and Aaron Stiefel participated in, a seminar given by the Practising Law Institute titled "Developments in Pharmaceutical and Biotech Patent Law" in New York on September 11, 2008 and in San Francisco on October 15, 2008. Mr. Barr spoke on "The Law of Active Pharmaceutical Ingredients and Impact of KSR," Mr. Reisner spoke on "Pharmaceutical and Biotech Related Transactions: Due Diligence, Practical Considerations and Antitrust Issues" and "Bench Perspective: Trying a Pharmaceutical or Biotech Patent Case," and Mr. Stiefel spoke on "The Section 271(e)(1) Safe Harbor and Research Tools."

For more information on these seminars, please visit:

ttp://www.pli.edu/product/seminar_detail.asp?id=45391
http://www.pli.edu/product/seminar_detail.asp?id=45392
http://www.pli.edu/product/webcast_detail.asp?id=45395

September 11, 2008